3-(3-(4-(4,4-difluoropiperidin-1-yl)-5-fluoropyrimidin-2-yl)-1-(2-fluorobenzyl)-1H-pyrazol-5-yl)isoxazole

ID: ALA4877042

PubChem CID: 90446380

Max Phase: Preclinical

Molecular Formula: C22H18F4N6O

Molecular Weight: 458.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1ccccc1Cn1nc(-c2ncc(F)c(N3CCC(F)(F)CC3)n2)cc1-c1ccon1

Standard InChI:  InChI=1S/C22H18F4N6O/c23-15-4-2-1-3-14(15)13-32-19(17-5-10-33-30-17)11-18(29-32)20-27-12-16(24)21(28-20)31-8-6-22(25,26)7-9-31/h1-5,10-12H,6-9,13H2

Standard InChI Key:  WDQRQGALDHXSHN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   34.5243  -26.8724    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   33.9465  -27.4543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7393  -27.6638    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.0448  -23.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0437  -24.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7517  -24.4111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4614  -24.0017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4585  -23.1790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7499  -22.7737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3356  -24.4102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3350  -25.2274    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.6745  -25.7032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9264  -26.4806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7436  -26.4813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9966  -25.7043    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9025  -25.4496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6518  -24.6718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.8346  -24.6699    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.5802  -25.4465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2402  -25.9283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2232  -27.1403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8887  -27.8871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3678  -28.5481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1815  -28.4636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5137  -27.7124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0326  -27.0545    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6622  -29.1245    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   29.3370  -22.7742    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.3262  -27.6247    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8051  -28.2865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6142  -28.2011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4673  -26.7933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6519  -26.8777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 12 16  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 14 21  1  0
 24 27  1  0
  4 28  1  0
 25 29  1  0
 29 30  1  0
 29 33  1  0
 30 31  1  0
 31  2  1  0
  2 32  1  0
 32 33  1  0
M  END

Associated Targets(Human)

GUCY1B1 Tclin Soluble guanylate cyclase (679 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.42Molecular Weight (Monoisotopic): 458.1478AlogP: 4.56#Rotatable Bonds: 5
Polar Surface Area: 72.87Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.75CX LogP: 5.23CX LogD: 5.23
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.41Np Likeness Score: -1.65

References

1. Rennie GR, Barden TC, Bernier SG, Carvalho A, Deming R, Germano P, Hudson C, Im GJ, Iyengar RR, Jia L, Jung J, Kim E, Lee TW, Mermerian A, Moore J, Nakai T, Perl NR, Tobin J, Zimmer DP, Renhowe PA..  (2021)  Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulator.,  40  [PMID:33662540] [10.1016/j.bmcl.2021.127886]

Source